Massimo Pieri

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects”.

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects

International Immunopharmacology(2021)10.1016/j.intimp.2021.108215

N/A

1.2DataRank · unranked

26 citations

Marzia Nuccetelli, Massimo Pieri, Serena Sarubbi, Martina Pelagalli, Graziella Calugi +3 more

SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines

Journal of Medical Virology(2024)10.1002/jmv.29527

N/A

0DataRank · unranked

17 citations

Maria K. Smatti, Duaa W. Al‐Sadeq, Hebah A. Al-Khatib, Eleonora Nicolai, Massimo Pieri +10 more